SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease

Gastroenterology

Volumn 138, Issue 4, 2010, Pages

  Schwimmer, Jeffrey B ^a,b,c   Dunn, Winston ^d   Norman, Gregory J ^e   Pardee, Perrie E ^a   Middleton, Michael S ^c   Kerkar, Nanda ^f   Sirlin, Claude B ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis; Nonalcoholic Fatty Liver Disease; Obesity; Patient Safety

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOLOGY; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CHRONIC LIVER DISEASE; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

EID: 77949816251     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.052     Document Type: Article

References (26)

1. Jonas M.M. Children with hepatitis C. Hepatology 36 (2002) S173-S178
2. Barlow S., and Expert Committee. Expert Committee Recommendations on the Assessment, Prevention, and Treatment of Child and Adolescent Overweight and Obesity, Summary Report. Pediatrics 120 Suppl 4 (2007) S164-S192
3. August G.P., Caprio S., Fennoy I., et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 93 (2008) 4576-4599
4. Lau D.C. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 176 (2007) 1103-1106
5. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002) 1-10
6. Schwimmer J.B., Deutsch R., Rauch J.B., et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143 (2003) 500-505
7. Schwimmer J.B., Pardee P.E., Lavine J.E., et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118 (2008) 277-283
8. Korenblat K.M., Fabbrini E., Mohammed B.S., et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134 (2008) 1369-1375
9. Schwimmer J.B., Celedon M.A., Lavine J.E., et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 136 (2009) 1585-1592
10. Dixon W.T. Simple proton spectroscopic imaging. Radiology 153 (1984) 189-194
11. Hussain H.K., Chenevert T.L., Londy F.J., et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 237 (2005) 1048-1055
12. Liu C.Y., McKenzie C.A., Yu H., et al. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 58 (2007) 354-364
13. Bydder M., Yokoo T., Hamilton G., et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26 (2008) 347-359
14. Yu H., McKenzie C.A., Shimakawa A., et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 26 (2007) 1153-1161
15. Uygun A., Kadayifci A., Yesilova Z., et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95 (2000) 3584-3589
16. Neuschwander-Tetri B.A., Unalp A., and Creer M.H. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med 168 (2008) 663-666
17. Gupta N.K., and Lewis J.H. Review article: the use of potentially hepatotoxic drugs in patients with liver disease. Aliment Pharmacol Ther 28 (2008) 1021-1041
18. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
19. Schwimmer J.B., Deutsch R., Kahen T., et al. Prevalence of fatty liver in children and adolescents. Pediatrics 118 (2006) 1388-1393
20. Zimmerman H.J. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver (1978), Appleton-Century-Crofts, New York
21. Davidson C.S., Leevy C.M., and Chamberlayne E.C. Guidelines for detection of hepatotoxicity due to drugs and chemicals. Fogarthy Conference, 1978 (1979) Washington, DC: NIH Publication no. 79-313
22. Senior J.R. Drug hepatotoxicity from a regulatory perspective. Clin Liver Dis 11 (2007) 507-524 vi
23. Bjornsson E., and Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42 (2005) 481-489
24. Navarro V.J., and Senior J.R. Drug-related hepatotoxicity. N Engl J Med 354 (2006) 731-739
25. Watkins P.B., and Seeff L.B. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 43 (2006) 618-631
26. Cox E.R., Halloran D.R., Homan S.M., et al. Trends in the prevalence of chronic medication use in children: 2002-2005. Pediatrics 122 (2008) e1053-e1061